Patents by Inventor Wolfgang Petsch

Wolfgang Petsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240101608
    Abstract: The present invention provides optimized nucleic acid molecules, methods for optimization of nucleic acid molecules and uses of optimized nucleic acid molecules. A modular design principle is provided that is suitable to generate a nucleic acid, particularly mRNA, which is tailored for a respective application. The nucleic acid molecules of the present invention can be obtained by the versatile combination of multiple modules on nucleic acid level. Such nucleic acid, e.g. mRNA, can be tailored by combining one or more modules, comprising (i) a nucleic acid moiety encoding a polypeptide of interest (e.g. a protein potentially producing a therapeutic outcome) and (ii) at least one further coding or non-coding nucleic acid moiety, e.g.
    Type: Application
    Filed: December 4, 2023
    Publication date: March 28, 2024
    Applicant: CureVac SE
    Inventors: Patrick BAUMHOF, Susanne RAUCH, Aleksandra KOWALCZYK, Johannes LUTZ, Edith JASNY, Benjamin PETSCH, Andreas THESS, Thomas SCHLAKE, Mariola FOTIN-MLECZEK, Regina HEIDENREICH, Sandra LAZZARO, Fatma FUNKNER, Wolfgang GROSSE
  • Publication number: 20240066114
    Abstract: The present invention is inter alia directed to compositions comprising at least one nucleic acid encoding at least one antigenic peptide or protein selected or derived from a Coronavirus membrane protein (M), nucleocapsid protein (N), non-structural protein, and/or accessory protein or an immunogenic fragment or immunogenic variant thereof. The composition may additionally comprise at least one nucleic acid encoding at least one antigenic peptide or protein selected or derived from a Coronavirus spike protein (S). The nucleic acid sequences of the compositions are preferably in association with a polymeric carrier, a polycationic protein or peptide, or a lipid nanoparticle (LNP). The compositions provided herein are for use in treatment or prophylaxis of an infection with at least one Coronavirus, and may therefore be comprised in a vaccine, preferably a multivalent vaccine.
    Type: Application
    Filed: August 30, 2021
    Publication date: February 29, 2024
    Applicant: CureVac SE
    Inventors: Susanne RAUCH, Nicole ROTH, Benjamin PETSCH, Wolfgang GROSSE
  • Publication number: 20070235035
    Abstract: This invention relates to a method of producing an auto induced biological barrier against spermatozoids and/or other microorganisms including viruses and/or pre cancers or non invasive cancers involving the production of an autoimmune reaction in a host in need of such auto-inducement.
    Type: Application
    Filed: June 4, 2007
    Publication date: October 11, 2007
    Inventors: Wolfgang Petsch, Eric Lardinois, Giorgio Maritan
  • Publication number: 20070190048
    Abstract: This invention relates to a method of inducing an auto-immune reaction in a host in need of such inducement. The invention is characterised in that stressful stimuli are applied to the vaginal and cervical mucosa by warming, prior to sexual intercourse, said vaginal and cervical mucosa to a physiologically acceptable but stress inducing temperature degree. The invention also relates to a device for using said method comprising a hollow body (1) provided with a heat source on the inside as well as with a means (13, 27) of removal of said hollow body from the vaginal or rectal cavity and a means (6, 8, 10) capable of exchanging heat originating from the hollow body.
    Type: Application
    Filed: December 5, 2006
    Publication date: August 16, 2007
    Inventors: Eric Lardinois, Giorgio Maritan, Wolfgang Petsch